Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03315572 · ClinicalTrials.gov registry record

Pediatric Ease of Use ELLIPTA Items

A clinical trial of Asthma, sponsored by GlaxoSmithKline.

Completed
Registry status
28
Enrollment target
2
Study locations

NCT03315572 is a study of Asthma that has completed, run by GlaxoSmithKline. The registered enrollment target is 28 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03315572, a study of Asthma, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
28 participants
Enrollment target
2
Study locations

Study Summary

A range of devices has been developed to administer inhaled therapy for asthma, including dry powder inhaler (DPI) devices. ELLIPTA is a DPI that is preloaded with a drug therapy to treat asthmatic subjects. The objective of this study is to revise ease of use items developed for adults to be appropriate for completion by pediatric subjects in future clinical trials and to evaluate the newly developed items in subjects with asthma aged 5 to 11 years and their caregivers. This is a cross-sectional, qualitative study that will involve pediatric subjects with asthma who are currently using an asthma maintenance inhaler and their caregivers. Two rounds of repetitive cognitive interviews will be conducted with 16 subjects in each interview set. Each interview will last approximately 45 minutes. Data provided by pediatric subjects and their caregivers during interview will be collected as field notes and audio recordings which will be transcribed.

Conditions Studied

Asthma

Interventions

  • OTHER Interviewer administered version of ease of use items
  • OTHER Self-administered version of ease of use items
  • OTHER Caregiver version of ease of use items

Study Locations (2)

Michigan

  • GSK Investigational Site - Southfield

North Carolina

  • GSK Investigational Site - Raleigh

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2017-10-17
Est. Completion 2017-12-01

Sponsor

GlaxoSmithKline

1,345 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03315572

The ClinicalTrials.gov registry entry for NCT03315572 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which Interviewer administered version of ease of use items is the first listed.

NCT03315572 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, North Carolina.

Frequently Asked Questions

What is clinical trial NCT03315572 about?

NCT03315572 is a clinical study titled "Pediatric Ease of Use ELLIPTA Items". A range of devices has been developed to administer inhaled therapy for asthma, including dry powder inhaler (DPI) devices. ELLIPTA is a DPI that is preloaded with a drug therapy to treat asthmatic subjects. The objective of this study is to revise ease of use items developed for adults to be approp...

What is the current status of trial NCT03315572?

This trial is currently completed. The enrollment target is 28 participants. The study started on 2017-10-17. Estimated completion is 2017-12-01.

What conditions does trial NCT03315572 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT03315572?

The interventions under investigation include: Interviewer administered version of ease of use items (OTHER), Self-administered version of ease of use items (OTHER), Caregiver version of ease of use items (OTHER).

Who is sponsoring clinical trial NCT03315572?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03315572 being conducted?

This trial has 2 study locations across Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.